4930455F23Rik Inhibitors
Chemical inhibitors of the protein 4930455F23Rik can act through various mechanisms to disrupt its function. Acetazolamide, by inhibiting carbonic anhydrase, can lead to altered bicarbonate ion production, affecting pH homeostasis and ion transport, which are essential for the stability or activity of 4930455F23Rik. Similarly, Methotrexate's inhibition of dihydrofolate reductase affects nucleotide synthesis, impeding cell cycle progression and DNA repair mechanisms that may be vital for 4930455F23Rik's optimal functioning. Allopurinol's inhibition of xanthine oxidase reduces the production of uric acid and reactive oxygen species, which could interfere with signaling pathways involving 4930455F23Rik. Aminoguanidine, by reducing nitric oxide production, can affect protein S-nitrosylation and nitrosative stress responses, potentially inhibiting 4930455F23Rik if it is sensitive to these cellular changes.
Additionally, Disulfiram's action on aldehyde dehydrogenase can lead to aldehyde accumulation, which may indirectly inhibit 4930455F23Rik if its activity is dependent on aldehyde metabolism. The autophagy inhibitor 3-Methyladenine can cause an accumulation of 4930455F23Rik by disrupting its turnover if the protein relies on autophagic processes. Bortezomib, targeting the 26S proteasome, can inhibit the degradation of ubiquitinated proteins, potentially leading to the buildup of damaged or misfolded 4930455F23Rik and disrupting protein homeostasis. Chloroquine, by impairing lysosomal function due to increased lysosomal pH, can inhibit 4930455F23Rik if lysosomal pathways are crucial for its activity. Lithium chloride's inhibition of glycogen synthase kinase-3 may alter the phosphorylation state of 4930455F23Rik, leading to its functional inhibition. Rapamycin, an mTOR inhibitor, can disrupt signaling pathways essential for 4930455F23Rik's activity, while Sorafenib's inhibition of tyrosine protein kinases can obstruct phosphorylation signals needed for 4930455F23Rik function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
Acetazolamide inhibits carbonic anhydrase, which can decrease the production of bicarbonate ions. A reduction in bicarbonate levels can disrupt pH homeostasis and ion transport processes within cells, potentially leading to the functional inhibition of 4930455F23Rik if it relies on these cellular conditions for its stability or activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate acts by inhibiting dihydrofolate reductase, leading to reduced production of tetrahydrofolate and consequently affecting nucleotide synthesis. This action can disrupt the cell cycle and DNA repair mechanisms, which might be necessary for the optimal functioning of 4930455F23Rik, thereby indirectly inhibiting its activity within the cell. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol inhibits xanthine oxidase, which can reduce the production of uric acid and reactive oxygen species. This alteration in oxidative stress levels and purine metabolism can interfere with signaling pathways that 4930455F23Rik is involved in, leading to its functional inhibition. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram inhibits aldehyde dehydrogenase, which can lead to an accumulation of aldehydes. If 4930455F23Rik requires aldehyde dehydrogenase activity or is sensitive to aldehydes for its function, disulfiram can indirectly inhibit its activity by disrupting aldehyde metabolism. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the 26S proteasome, which is responsible for degrading ubiquitinated proteins. If the function of 4930455F23Rik is regulated by proteasomal degradation, bortezomib's action can lead to the accumulation of improperly folded or damaged 4930455F23Rik, causing functional inhibition due to a disruption in protein homeostasis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises lysosomal pH by accumulating within the lysosome and preventing acidification. If 4930455F23Rik is dependent on lysosomal degradation pathways for its activity, chloroquine can functionally inhibit 4930455F23Rik by impairing lysosomal function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), which is involved in numerous cellular processes including phosphorylation of proteins. If the activity of 4930455F23Rik is regulated by phosphorylation events controlled by GSK-3, lithium chloride can lead to its functional inhibition by altering its phosphorylation state. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt cell growth and metabolic signaling pathways. If 4930455F23Rik activity is tied to the mTOR signaling pathway, rapamycin would inhibit 4930455F23Rik by impeding the essential signals required for its function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib inhibits multiple tyrosine protein kinases, and if 4930455F23Rik's function is dependent on a signaling cascade involving these kinases, sorafenib can lead to functional inhibition of 4930455F23Rik by obstructing the necessary phosphorylation signals. | ||||||